Abstract:Agonist stimulation of G protein-coupled receptors (GPCRs) can transactivate epidermal growth factor receptors (EGFRs), but the precise mechanisms for this transactivation have not been defined. Key to this process is the protease-mediated "shedding" of membrane-tethered ligands, which then activate EGFRs. The specific proteases and the events involved in GPCR-EGFR transactivation are not fully understood. We have tested the hypothesis that transactivation can occur by a membrane-delimited process: direct increase in the activity of membrane type-1 matrix metalloprotease (MMP14, MT1-MMP) by heterotrimeric G proteins, and in turn, the generation of heparin-binding epidermal growth factor (HB-EGF) and activation of EGFR. Using membranes prepared from adult rat cardiac myocytes and fibroblasts, we found that MMP14 activity is increased by angiotensin II, phenylephrine, GTP, and guanosine 5'-O-[γ-thio]triphosphate (GTPγS). MMP14 activation by GTPγS occurs in a concentration- and time-dependent manner, does not occur in response to GMP or adenosine 5'-[γ-thio]triphosphate (ATPγS), and is not blunted by inhibitors of Src, PKC, phospholipase C (PLC), PI3K, or soluble MMPs. This activation is specific to MMP14 as it is inhibited by a specific MMP14 peptide inhibitor and siRNA knockdown. MMP14 activation by GTPγS is pertussis toxin-sensitive. A role for heterotrimeric G protein βγ subunits was shown by using the Gβγ inhibitor gallein and the direct activation of recombinant MMP14 by purified βγ subunits. GTPγS-stimulated activation of MMP14 also results in membrane release of HB-EGF and the activation of EGFR. These results define a previously unrecognized, membrane-delimited mechanism for EGFR transactivation via direct G protein activation of MMP14 and identify MMP14 as a heterotrimeric G protein-regulated effector.

GAIN domain–mediated cleavage is required for activation of G protein–coupled receptor 56 (GPR56) by its natural ligands and a small-molecule agonist

Structural basis of adhesion GPCR GPR110 activation by stalk peptide and G-proteins coupling

Structural basis of tethered agonism of the adhesion GPCRs ADGRD1 and ADGRF1

Conformational Transitions and Activation of the Adhesion Receptor CD97.

G protein selectivity profile of GPR56/ADGRG1 and its effect on downstream effectors

Crystal Structure of the Extracellular Domains of GPR110

Optimization of a peptide ligand for the adhesion GPCR ADGRG2 provides a potent tool to explore receptor biology

Structural insights into adhesion GPCR ADGRL3 activation and Gq, Gs, Gi, and G12 coupling

Toward a Structural Understanding of Class B GPCR Peptide Binding and Activation.

Mechanisms of peptide agonist dissociation and deactivation of adhesion G-protein-coupled receptors

Unveiling Mechanical Activation: GAIN Domain Unfolding and Dissociation in Adhesion GPCRs

Conformational coupling between extracellular and transmembrane domains modulates holo-adhesion GPCR function

Structural Basis for the Activation of Proteinase-Activated Receptors (PARs) by Endogenous Ligands

Structure basis of ligand recognition and activation of GPR55

Structural analysis and conformational dynamics of a holo-adhesion GPCR reveal interplay between extracellular and transmembrane domains

The GPCR, class C, group 6, subtype A (GPRC6A) receptor: from cloning to physiological function

Heterotrimeric G proteins directly regulate MMP14/membrane type-1 matrix metalloprotease: a novel mechanism for GPCR-EGFR transactivation

Structural basis for the tethered peptide activation of adhesion GPCRs

Constitutive activation mechanism of a class C GPCR

A non-canonical mechanism of GPCR activation

Structures of the glucocorticoid-bound adhesion receptor GPR97–Go complex